Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

New England Journal of Medicine

Volumn 314, Issue 4, 1986, Pages 202-207

  Goldman, John M ^a,b,c,d   Apperley, Jane F ^e   Jones, Lydia ^e   Marcus, Robert ^e   Goolden, Alan W g ^e   Batchelor, Richard ^e   Hale, Geoffrey ^e   Waldmann, Herman ^e   Reid, Cecil D ^e   Hows, Jill ^e   Gordon Smith, Edward ^e   Catovsky, Daniel ^e   Galton, David A g ^e  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MONOCLONAL ANTIBODY;

BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOTHERAPY; SPLEEN; SPLENECTOMY; T LYMPHOCYTE; THERAPY;

EID: 0022643765     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198601233140403     Document Type: Article

References (27)

1. Fefer A, Cheever MA, Thomas ED, et al. Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin. N Engl J Med 1979; 300: 333–7.
2. Fefer A, Cheever MA, Greenberg PD. Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. N Engl J Med 1982; 306: 63–8.
3. Goldman JM, Johnson SA, Catovsky D, Agnarsdottir G, Goolden AWG, Galton DAG. Identical twin marrow transplantation for patients with leukemia and lymphoma. Transplantation 1981; 31: 140–1.
4. Curtis JE, Messner HA. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility. Can Med Assoc J 1981; 126: 649–55.
5. Doney KC, Buckner CD, Thomas ED, et al. Allogeneic bone marrow transplantation for chronic granulocytic leukemia. Exp Hematol 1981; 9: 966–71.
6. Clift RA, Buckner CD, Thomas ED, et al. Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet 1982; 2: 621–3.
7. Goldman JM, Baughan ASJ, McCarthy DM, et al. Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet 1982; 2: 623–5.
8. Speck B, Gratwohl A, Nissen C. Allogeneic marrow transplantation for chronic granulocytic leukemia. Blut 1982; 45: 237–42.
9. Champlin R, Ho W, Arenson E, Gale RP. Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase. Blood 1982; 60: 1038–41.
10. Goldman JM, Baughan A. Application of bone marrow transplantation in chronic granulocytic leukaemia. Clin Haematol 1983; 12: 739–53.
11. Goolden AWG, Goldman JM, Kam KC, et al. Fractionation of whole body irradiation before bone marrow transplantation for patients with leukaemia. Br J Radiol 1983; 56: 245–50.
12. Hows JM, Mehta A, Ward L, et al. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomized study. Br J Cancer 1984; 50: 753–6.
13. Donnelly P, Marcus RE, Goldman JM, et al. Ceftazidime as first-line therapy for fever in acute leukaemia. J Infect Dis (in press).
14. Prentice HG, Blacklock HA, Janossy G, et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984; 1: 472–6.
15. Waldmann H, Polliak A, Hale G, et al. Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (Campath-1). Lancet 1984; 2: 483–6.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
17. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39.
18. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949:191–205.
19. McGlave PB, Arthur DC, Kim TH, Ramsay NKC, Hurd DD, Kersey J. Successful allogeneic bone-marrow transplantation for patients in the accelerated phase of chronic granulocytic leukaemia. Lancet 1982; 2: 625–7.
20. Speck B, Bortin MM, Champlin R, et al. Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet 1984; 1: 665–8.
21. Marmont A, Frassoni F, Bacigalupo A, et al. Recurrence of Ph′-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia. N Engl J Med 1984; 310: 903–6.
22. Thomas ED, Clift RA, Fefer A, et al. Marrow transplantation for treatment of chronic granulocytic leukemia. Ann Intern Med (in press).
23. Smith JL, Heerema NA, Provisor AJ. Leukaemic transformation of engrafted bone marrow cells. Br J Haematol 1985; 60: 415–22.
24. Patterson J, Prentice HG, Brenner MK, et al. Graft rejection following HLA-matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol (in press).
25. Gluckman E, Devergie A, Bernheim A, Berger R. Splenectomy and bone marrow transplantation in chronic granulocytic leukaemia. Lancet 1983; 1: 1392–3.
26. Banaji M, Bearman SI, Buckner CD, et al. The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukaemia undergoing marrow transplantation. Br J Haematol (in press).
27. Gratwohl A, Goldman J, Gluckman E, Zwaan F. Effect of splenectomy before bone-marrow transplantation on survival in chronic granulocytic leukaemia. Lancet 1985; 2: 1290–1.